" class="no-js "lang="en-US"> Encik Sasha Nordin - Pharmtech Focus
Tuesday, January 31, 2023
Encik Sasha Nordin

Encik Sasha Nordin

About Encik Sasha Nordin

Encik Sasha Nordin was appointed as the Chief Executive Officer (“CEO”) on 23 September 2020. Prior to his appointment as CEO of the Company, he was the Chief Operating Officer of the Company since 1 February 2014.

Prior to joining the Company, he was employed at Neuramatix Sdn Bhd, the previous ultimate holding company of Malaysian Genomics Resource Centre Berhad (“MGRC”), for a period of 12 years. In 2016, he was awarded a Master in Business Administration with Distinction from the University of Strathclyde, Glasgow.

Encik Sasha has over 21 years’ experience in business development, project planning and management, product development, and strategic marketing. He contributes to the growth needs of the Company. This has included the sourcing of grant and public funds for research and development, maintaining communications with strategic stakeholders, and contributing to strategic planning.

Encik Sasha does not have any directorships in other public companies and public listed companies. He does not have any family relationship with any directors and/or major shareholders of the Company and has no conflict of interest with the Company.

He has not been convicted of any offences within the last 5 years, other than traffic offences, if any, and public sanction or penalty imposed by the relevant regulatory bodies, during the financial year ended 30 June 2021.

Related Story

Malaysian Genomics Grows Presence in Thailand

September 26 2022

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is […]